Key result
Ticagrelor is a novel ADP receptor blocker that provides greater, more rapid, and more consistent platelet inhibition than clopidogrel for treating stent thrombosis in ACS patients undergoing PCI.
Why the study?
Does ticagrelor prevent stent thrombosis better than clopidogrel in acute coronary syndrome patients undergoing PCI?
Does ticagrelor prevent stent thrombosis better than clopidogrel in acute coronary syndrome patients undergoing PCI?
Ticagrelor provides a more consistent and rapid antiplatelet response compared to clopidogrel, making it a promising agent for preventing stent thrombosis in post-PCI patients.
Answers are grounded in this paper and cite their sources.
Ticagrelor may overcome clopidogrel resistance in stent thrombosis cases; leaves open need for randomized trials before practice change.
Stent thrombosis is a morbid complication following percutaneous coronary intervention (PCI). Dual antiplatelet therapy significantly reduces stent thrombosis risk. However, the antiplatelet response to clopidogrel - the most frequently used ADP receptor antagonist in post-PCI patients - varies among individuals. High on-treatment platelet reactivity was repeatedly associated with the risk of stent thrombosis. Ticagrelor is a novel ADP receptor blocker that has shown greater, more rapid and more consistent platelet inhibition than clopidogrel. This agent offers a unique mechanism of action, no relevant pharmacological interactions, consistent platelet inhibition, and a good safety profile. This article reviews the prospective use of ticagrelor in the treatment of stent thrombosis in acute coronary syndrome patients undergoing PCI of culprit coronary lesion.
No takes yet. Share an insight, caveat, or question.
Samoš et al. (2015) conducted a review in Stent thrombosis in acute coronary syndrome patients undergoing PCI. Ticagrelor vs. Clopidogrel was evaluated. Ticagrelor is a novel ADP receptor blocker that provides greater, more rapid, and more consistent platelet inhibition than clopidogrel for treating stent thrombosis in ACS patients undergoing PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: